The Role of Inflammatory Markers for Risk Stratification and Prognosis in Dialysis Patients: A Narrative Review

Chronic inflammation is a prevalent condition among dialysis patients and is associated with adverse health outcomes. This narrative review aims to provide a comprehensive analysis of the types and roles of inflammatory markers in risk assessment and their impact on the prognosis of dialysis patients. The associations between various inflammatory markers, including C-Reactive Protein (CRP), anti-inflammatory markers (IL-4, IL-10), and pro-inflammatory markers (TNF-α, IL-1, IL-6, IL-12), are evaluated in relation to their ability to predict mortality and cardiovascular complications in this population. Additionally, the potential of these markers for individualized risk stratification is discussed, aiding proper clinical decision-making and improving patient care. This review synthesizes current knowledge on inflammatory markers and their impact on the outcomes of dialysis patients, offering insights for improved prognostic assessment and therapeutic strategies.